Servier Ventures

Servier Ventures Servier Ventures launched in January 2026 as the first CVC initiative for Servier, France's largest private pharmaceutical company. The commitment is €200M (roughly $234M) to the European biotech sector, focused on oncology and neurology therapeutics aligned with Servier's core therapeutic areas. The fund takes minority stakes in innovative biotech and technology companies, with an initial European focus and potential expansion to other regions. Being part of a private pharma co